Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection | Zendy

Samuel A. Bozzette | Zendy; Christopher F. Ake | Zendy; Henry K. Tam | Zendy; Sophia W. Chang | Zendy; Thomas A. Louis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection

Author(s) -

Samuel A. Bozzette,

Christopher F. Ake,

Henry K. Tam,

Sophia W. Chang,

Thomas A. Louis

Publication year - 2003

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa022048

Subject(s) - medicine , hazard ratio , reverse transcriptase inhibitor , mortality rate , protease inhibitor (pharmacology) , retrospective cohort study , reverse transcriptase , viral load , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , confidence interval , rna , biochemistry , chemistry , gene

Metabolic abnormalities associated with human immunodeficiency virus (HIV) infection, including dysglycemia and hyperlipidemia, are increasingly prevalent, and there is concern about the possibility of an association with accelerated cardiovascular and cerebrovascular disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research